GD1 COST-UTILITY ANALYSIS OF RABEPRAZOLE AND ESOMEPRAZOLE FOR SYMPTOMATIC GASTRO OESOPHAGEAL REFLUX DISEASE
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61575-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)61575-6/fulltext
Title :
GD1 COST-UTILITY ANALYSIS OF RABEPRAZOLE AND ESOMEPRAZOLE FOR SYMPTOMATIC GASTRO OESOPHAGEAL REFLUX DISEASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61575-6&doi=10.1016/S1098-3015(10)61575-6
First page :
Section Title :
Open access? :
No
Section Order :
20